Guildford, UK: MedPharm Ltd (www.medpharm.com), the topical and transdermal formulation development specialist, today announced a further expansion of their base on the Surrey Research Park, increasing laboratory and office space by a third.

“To accommodate our ever-increasing range of services and growing staff numbers, we have added new laboratory and office space to our company base on the Surrey Research Park in Guildford. This is symbolic of how our business has gone from strength to strength in the provision of formulation development and manufacturing services to our clients and the ongoing work on our proprietary drug delivery technologies,” commented Dr. Andrew Muddle, CEO.

The addition of new laboratories and offices combined with the opening of the GMP approved clinical trial materials manufacturing facility in Q4 of 2013, has doubled MedPharm’s footprint in 12 months.

Dr. Muddle continues, “The new spaces are equipped to the highest standard and we look forward to welcoming our clients to our company headquarters and research, development and manufacturing facilities. This extra capacity is the result of increasing demand for our services. I would like to thank our clients for their ongoing custom and our staff for continuing to uphold the highest levels of service, quality and technical expertise that continues to ensure that we are the leaders in our field.”

Back to News